OncoSil Medical Limited (OSL.AX)
AUD 0.01
(-14.29%)
AUD 0.01
(-14.29%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -11.97 Million AUD | -5.84% |
| 2023 | -11.31 Million AUD | -9.71% |
| 2022 | -11.41 Million AUD | 1.4% |
| 2021 | -10.5 Million AUD | -62.07% |
| 2020 | -6.86 Million AUD | 42.94% |
| 2019 | -12.15 Million AUD | 5.18% |
| 2018 | -12.94 Million AUD | -21.04% |
| 2017 | -10.43 Million AUD | -21.8% |
| 2016 | -8.58 Million AUD | -56.43% |
| 2015 | -2.89 Million AUD | -20.56% |
| 2014 | -4.16 Million AUD | -376.09% |
| 2013 | -876.96 Thousand AUD | -137.79% |
| 2012 | -430.79 Thousand AUD | 17.76% |
| 2011 | -638.18 Thousand AUD | -123.51% |
| 2010 | 59.2 Thousand AUD | 1092.82% |
| 2009 | -582.28 Thousand AUD | 93.55% |
| 2008 | -3.09 Million AUD | -59.38% |
| 2007 | -1.99 Million AUD | -645.1% |
| 2006 | -281.98 Thousand AUD | -1021.8% |
| 2005 | -26.34 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | -6.83% |
| 2024 Q2 | -6.53 Million AUD | 0.0% |
| 2024 Q4 | -6.64 Million AUD | 0.0% |
| 2023 FY | - AUD | -9.71% |
| 2023 Q4 | -6.12 Million AUD | 0.0% |
| 2023 Q2 | -6.24 Million AUD | 0.0% |
| 2022 FY | - AUD | 1.4% |
| 2022 Q2 | -6.06 Million AUD | 0.0% |
| 2022 Q4 | -5.21 Million AUD | 0.0% |
| 2021 Q4 | -6.03 Million AUD | 0.0% |
| 2021 Q2 | -5.41 Million AUD | 0.0% |
| 2021 FY | - AUD | -62.07% |
| 2020 Q4 | -2.5 Million AUD | 0.0% |
| 2020 FY | - AUD | 42.94% |
| 2020 Q2 | -4.55 Million AUD | 0.0% |
| 2019 FY | - AUD | 5.18% |
| 2019 Q4 | -3.49 Million AUD | 0.0% |
| 2019 Q2 | -5.25 Million AUD | 0.0% |
| 2018 Q4 | -4.06 Million AUD | 0.0% |
| 2018 FY | - AUD | -21.04% |
| 2018 Q2 | -4.54 Million AUD | 0.0% |
| 2017 Q2 | -3.31 Million AUD | 0.0% |
| 2017 FY | - AUD | -21.8% |
| 2017 Q4 | -3.95 Million AUD | 0.0% |
| 2016 FY | - AUD | -56.43% |
| 2016 Q2 | -1.86 Million AUD | 0.0% |
| 2016 Q4 | -3.14 Million AUD | 0.0% |
| 2015 FY | - AUD | -20.56% |
| 2015 Q4 | -598.2 Thousand AUD | 0.0% |
| 2015 Q2 | -2.29 Million AUD | 0.0% |
| 2014 Q4 | -2.28 Million AUD | 0.0% |
| 2014 FY | - AUD | -376.09% |
| 2014 Q2 | -1.87 Million AUD | 0.0% |
| 2013 Q4 | -672.7 Thousand AUD | -206.06% |
| 2013 Q1 | -107.74 Thousand AUD | 0.0% |
| 2013 Q2 | -207.18 Thousand AUD | -92.3% |
| 2013 Q3 | -219.79 Thousand AUD | -6.08% |
| 2013 FY | - AUD | -137.79% |
| 2012 Q2 | -107.74 Thousand AUD | 70.44% |
| 2012 FY | - AUD | 17.76% |
| 2012 Q3 | -107.74 Thousand AUD | 0.0% |
| 2012 Q1 | -364.5 Thousand AUD | 0.0% |
| 2012 Q4 | -107.74 Thousand AUD | 0.0% |
| 2011 Q1 | -521.58 Thousand AUD | 0.0% |
| 2011 Q3 | -364.5 Thousand AUD | 0.0% |
| 2011 FY | - AUD | -123.51% |
| 2011 Q4 | -364.5 Thousand AUD | 0.0% |
| 2011 Q2 | -364.5 Thousand AUD | 30.12% |
| 2010 Q3 | -521.58 Thousand AUD | 0.0% |
| 2010 Q2 | -521.58 Thousand AUD | -135.35% |
| 2010 FY | - AUD | 1092.82% |
| 2010 Q4 | -521.58 Thousand AUD | 0.0% |
| 2010 Q1 | -221.61 Thousand AUD | 0.0% |
| 2009 FY | - AUD | 93.55% |
| 2009 Q4 | -221.61 Thousand AUD | 0.0% |
| 2009 Q1 | -665.89 Thousand AUD | 0.0% |
| 2009 Q2 | -221.61 Thousand AUD | 66.72% |
| 2009 Q3 | -221.61 Thousand AUD | 0.0% |
| 2008 Q2 | -665.89 Thousand AUD | -69.57% |
| 2008 Q1 | -392.69 Thousand AUD | 0.0% |
| 2008 FY | - AUD | -59.38% |
| 2008 Q4 | -665.89 Thousand AUD | 0.0% |
| 2008 Q3 | -665.89 Thousand AUD | 0.0% |
| 2007 Q4 | -392.69 Thousand AUD | 0.0% |
| 2007 Q2 | -392.69 Thousand AUD | -1425.4% |
| 2007 Q1 | -25.74 Thousand AUD | 0.0% |
| 2007 FY | - AUD | -645.1% |
| 2007 Q3 | -392.69 Thousand AUD | 0.0% |
| 2006 FY | - AUD | -1021.8% |
| 2006 Q4 | -25.74 Thousand AUD | 0.0% |
| 2006 Q2 | -25.74 Thousand AUD | -94.88% |
| 2006 Q1 | -13.21 Thousand AUD | 0.0% |
| 2006 Q3 | -25.74 Thousand AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q3 | -13.21 Thousand AUD | 0.0% |
| 2005 Q2 | -13.21 Thousand AUD | 0.0% |
| 2005 Q4 | -13.21 Thousand AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 66.794% |
| Adherium Limited | -11.56 Million AUD | -3.56% |
| Aroa Biosurgery Limited | -7.36 Million AUD | -62.718% |
| Atomo Diagnostics Limited | -5.42 Million AUD | -120.82% |
| Anteris Technologies Ltd | -66.9 Million AUD | 82.1% |
| Control Bionics Limited | -5.15 Million AUD | -132.177% |
| CardieX Limited | -6.71 Million AUD | -78.433% |
| Compumedics Limited | 2.78 Million AUD | 529.407% |
| Cochlear Limited | 579.5 Million AUD | 102.067% |
| CleanSpace Holdings Limited | -3.49 Million AUD | -242.979% |
| Cyclopharm Limited | -3.03 Million AUD | -294.615% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | -472.692% |
| Nova Eye Medical Limited | -5.97 Million AUD | -100.304% |
| HeraMED Limited | -3.97 Million AUD | -201.51% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | 45.24% |
| ImpediMed Limited | -22.05 Million AUD | 45.689% |
| InhaleRx Limited | -1.41 Million AUD | -747.125% |
| LBT Innovations Limited | -4.04 Million AUD | -195.781% |
| Micro-X Limited | -14.35 Million AUD | 16.548% |
| Neurotech International Limited | -8.24 Million AUD | -45.271% |
| PolyNovo Limited | 5.17 Million AUD | 331.647% |
| Respiri Limited | -7.04 Million AUD | -69.877% |
| SomnoMed Limited | -2.32 Million AUD | -414.305% |
| Universal Biosensors, Inc. | -9.09 Million AUD | -31.745% |
| Uscom Limited | -1.5 Million AUD | -693.486% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | -143.547% |